Inna Y Gong (Inna Gong)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Patients Undergoing

Coronavirus Disease

Prognostic Factors

Ejection Fraction

Top Venues

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Inna Y Gong, Daisy Tran, Samuel Saibil, Rob C Laister, John Kuruvilla
Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphoma. HemaSphere 8 (8) (2024)
Inna Y Gong, Daisy Tran, Samuel Saibil, Rob C Laister, John Kuruvilla
Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphoma. HemaSphere 8 (8) (2024)
Inna Y Gong, Anca Prica, Zharmaine Ante, Andrew Calzavara, Monika K Krzyzanowska, Simron Singh, Adam Suleman, Matthew C Cheung, Michael Crump
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada. British journal of haematology (2023)
Inna Y Gong, Abi Vijenthira, Stephen D Betschel, Lisa K Hicks, Matthew C Cheung
COVID-19 vaccine response in patients with hematologic malignancy: A systematic review and meta-analysis. American journal of hematology 97 (4) (2022)
Abi Vijenthira, Inna Y Gong, Stephen D Betschel, Matthew Cheung, Lisa K Hicks
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients. Blood advances 5 (12) (2021)